The Third Therapeutic Intervention In Malignant Effusion Trial (time3): A Randomised Controlled Trial To Assess Dyspnea Relief And Pleurodesis Success Following Intrapleural Urokinase In Patients With Non-Draining Malignant Pleural Effusion